Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma

被引:63
|
作者
Young, Jonathan R. [1 ]
Coy, Heidi [1 ]
Kim, Hyun J. [1 ]
Douek, Michael [1 ]
Lo, Pechin [1 ]
Pantuck, Allan J. [2 ]
Raman, Steven S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 757 Westwood Plaza,Ste 1638, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
关键词
MRI; multiphasic; oncocytoma; renal cell carcinoma; PATHOLOGICAL FINDINGS; HISTOLOGIC SUBTYPES; HELICAL CT; TUMORS; CLASSIFICATION; NEOPLASMS; PARAMETERS; FEATURES; DISEASE; SYSTEM;
D O I
10.2214/AJR.16.17152
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the performance of relative enhancement on multiphasic MRI to differentiate clear cell renal cell carcinoma (RCC) from other RCC subtypes (papillary and chromophobe) and oncocytoma. MATERIALS AND METHODS. For this study, we derived a cohort of 34 clear cell RCCs, nine oncocytomas, 12 papillary RCCs, and 10 chromophobe RCCs with a preoperative multiphasic dynamic contrast-enhanced MRI study with up to four phases (i.e., unenhanced, corticomedullary, nephrographic, excretory) from 2005 to 2016. These groups were evaluated for multiphasic enhancement and were compared using Kruskal-Wallis and Mann-Whitney tests. ROC curves were constructed and logistic regression analyses were performed to evaluate the performance of multiphasic enhancement in differentiating clear cell RCCs from the other three groups. RESULTS. Clear cell RCCs exhibited significantly greater relative signal intensity compared with uninvolved renal cortex in the corticomedullary phase (mean, 2.9) than oncocytomas (-21.7, p = 0.001), papillary RCCs (-53.0, p < 0.001), and chromophobe RCCs (-21.0, p < 0.001). Relative signal intensity in the corticomedullary phase differentiated clear cell RCCs from oncocytomas with an AUC of 0.90 and with an accuracy of 84% (32/38), sensitivity of 90% (27/30), and specificity of 63% (5/8) after controlling for lesion size, patient age, and patient sex. Relative corticomedullary signal intensity differentiated clear cell RCCs from oncocytomas and other RCC subtypes with an AUC of 0.93 and with an accuracy of 90% (53/59), sensitivity of 90% (27/30), and specificity of 90% (26/29) after controlling for lesion size, patient age, and patient sex. CONCLUSION. Multiphasic MRI enhancement may assist in differentiating clear cell RCC from oncocytomas and other RCC subtypes, if validated in prospective studies.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 50 条
  • [21] Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement
    Anna K. Paschall
    S. Mojdeh Mirmomen
    Rolf Symons
    Amir Pourmorteza
    Rabindra Gautam
    Amil Sahai
    Andrew J. Dwyer
    Maria J. Merino
    Adam R. Metwalli
    W. Marston Linehan
    Ashkan A. Malayeri
    Abdominal Radiology, 2018, 43 : 2424 - 2430
  • [22] Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement
    Paschall, Anna K.
    Mirmomen, S. Mojdeh
    Symons, Rolf
    Pourmorteza, Amir
    Gautam, Rabindra
    Sahai, Amil
    Dwyer, Andrew J.
    Merino, Maria J.
    Metwalli, Adam R.
    Linehan, W. Marston
    Malayeri, Ashkan A.
    ABDOMINAL RADIOLOGY, 2018, 43 (09) : 2424 - 2430
  • [23] Differential role of angiogenesis in clear cell and chromophobe renal cell carcinoma and oncocytoma
    Shen, R
    Zhang, H
    Li, X
    Bismar, T
    Sakr, W
    Grignon, D
    Che, M
    MODERN PATHOLOGY, 2003, 16 (01) : 171A - 171A
  • [24] Differential role of angiogenesis in clear cell and chromophobe renal cell carcinoma and oncocytoma
    Shen, R
    Zhang, H
    Li, X
    Bismar, T
    Sakr, W
    Grignon, D
    Che, M
    LABORATORY INVESTIGATION, 2003, 83 (01) : 171A - 171A
  • [25] Obesity, Cholesterol, and Clear-Cell Renal Cell Carcinoma (RCC)
    Drabkin, Harry A.
    Gemmill, Robert M.
    ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 : 39 - 56
  • [26] KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of conventional renal cell carcinoma
    Wang, HY
    Mills, SE
    MODERN PATHOLOGY, 2005, 18 : 170A - 170A
  • [27] Differentiation of Papillary Renal Cell Carcinoma Subtypes on CT and MRI
    Egbert, Nathan D.
    Caoili, Elaine M.
    Cohan, Richard H.
    Davenport, Matthew S.
    Francis, Isaac R.
    Kunju, L. Priya
    Ellis, James H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (02) : 347 - 355
  • [28] Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI
    Akin, Isil Basara
    Altay, Canan
    Guler, Ezgi
    Camlidag, Ilkay
    Harman, Mustafa
    Danaci, Murat
    Tuna, Burcin
    Yorukoglu, Kutsal
    Secil, Mustafa
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2019, 25 (01) : 5 - 13
  • [29] KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of conventional renal cell carcinoma
    Wang, HY
    Mills, SE
    LABORATORY INVESTIGATION, 2005, 85 : 170A - 170A
  • [30] Rapamycin mechanisms of action in renal clear cell carcinoma (RCC)
    Balducci, L
    Lambo, R
    Saldarelli, M
    Mancini, V
    Battaglia, M
    Ambrosi, A
    Dambrosio, M
    Pontrelli, P
    Stallone, G
    Grandaliano, G
    Schena, FP
    Gesualdo, L
    Ranieri, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V203 - V203